ePT--the Electronic Newsletter of Pharmaceutical Technology
Researchers at the University of Southern California's Information Sciences Institute (ISI) demonstrated a way to manufacture miniscule containers called voxels that could potentially deliver precise microdoses or even nanodoses of drugs.
Marina del Rey, CA (May 1)-Researchers at the University of Southern California’s Information Sciences Institute (ISI) demonstrated a way to manufacture miniscule containers called voxels that could potentially deliver precise microdoses or even nanodoses of drugs.
A team consisting of Peter Will, an ISI fellow and research professor, Alejandro Bugacov, a former postdoctoral researcher, Rob Gagler, a former graduate student, and Bruce Koel, a professor of chemistry at Lehigh University, created various shapes, including four- and five-sided pyramids, pentagonal lotus shapes, and simple square plates, which folded over each other to make flat mini-envelopes.
The USC team performed the experimental work on campus because ISI doesn’t have a wet laboratory. The researchers used “MEMSPRO CAD” software to design the chips, which were then fabricated in France.
According to an ISI press release, Will has been interested in creating voxels since “my days in HP labs, when I was working in medical and chemical applications.”
The National Science Foundation supported the research under an exploratory research grant. The team published a paper about the research, “Voxels: Volume-Enclosing Microstructures,” in the May 2008 issue of the Journal of Micromechanics and Microengineering.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.